Hennion & Walsh Asset Management, Inc. Hutchmed (China) LTD Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 60,009 shares of HCM stock, worth $889,933. This represents 0.04% of its overall portfolio holdings.
Number of Shares
60,009
Previous 61,124
1.82%
Holding current value
$889,933
Previous $1.19 Million
27.64%
% of portfolio
0.04%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding HCM
# of Institutions
70Shares Held
6.77MCall Options Held
8.2KPut Options Held
9.2K-
Schroder Investment Management Group London, X02.77MShares$41.1 Million0.04% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.12MShares$16.6 Million0.02% of portfolio
-
Ubs Group Ag378KShares$5.6 Million0.0% of portfolio
-
State Street Corp Boston, MA348KShares$5.15 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.68 Million0.12% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.56B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...